Performance of the HPV-16 L1 methylation assay and HPV E6/E7 mRNA test for the detection of squamous intraepithelial lesions in cervical cytological samples.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Virological Methods

• Publication date

  2015-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jviromet.2015.08.008PMID 26297960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HPV mRNA Is More Specific than HPV DNA in Triage of Women with Minor Cervical Lesions

  2014cited by this paper
• Increased methylation of Human Papillomavirus type 16 DNA correlates with viral integration in Vulval Intraepithelial Neoplasia.

  2014cited by this paper
• Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade.

  2014cited by this paper
• Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.

  2014cited by this paper
• Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.

  2014influential reference
• Comparison Study of MS-HRM and Pyrosequencing Techniques for Quantification of APC and CDKN2A Gene Methylation

  2013cited by this paper
• Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.

  2013cited by this paper
• Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia

  2013cited by this paper
• Quantivirus® HPV E6/E7 RNA 3.0 assay (bDNA) is as sensitive, but less specific than Hybrid Capture 2 test.

  2013cited by this paper
• Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.

  2012cited by this paper
• American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

  2012cited by this paper
• Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer

  2012cited by this paper
• Analytical performance of RNA isolated from BD SurePath™ cervical cytology specimens by the PreTect™ HPV-Proofer assay.

  2012cited by this paper
• A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples

  2012cited by this paper
• Oncogenic human papillomavirus imposes an instructive pattern of DNA methylation changes which parallel the natural history of cervical HPV infection in young women.

  2012cited by this paper
• Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA.

  2011cited by this paper
• Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients

  2011cited by this paper
• Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.

  2011cited by this paper
• Clinical performance of human papillomavirus E6, E7 mRNA flow cytometric assay compared to human papillomavirus DNA typing.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Clinical Performance of the PreTect HPV-Proofer E6/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer

  2010cited by this paper
• Type‐specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia

  2010cited by this paper
• Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

  2009cited by this paper
• Clinical Performance of Human Papillomavirus E6 and E7 mRNA Testing for High-Grade Lesions of the Cervix

  2009cited by this paper
• Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

  2008cited by this paper
• Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

  2007cited by this paper
• Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial.

  2007cited by this paper
• Prediction of recurrence after treatment for high‐grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation

  2006cited by this paper
• Genital human papillomavirus infection.

  2006cited by this paper
• Assessment of MagNA Pure LC Extraction System for Detection of Human Papillomavirus (HPV) DNA in PreservCyt Samples by the Roche AMPLICOR and LINEAR ARRAY HPV Tests

  2006cited by this paper
• Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial.

  2006cited by this paper
• Human Papillomavirus Type 16 Integration in Cervical Carcinoma In Situ and in Invasive Cervical Cancer

  2006cited by this paper
• Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

  2003cited by this paper
• The causal relation between human papillomavirus and cervical cancer.

  2002cited by this paper
• The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.

  2002cited by this paper
• The Human Papillomavirus Type 16 E 6 and E 7 Oncoproteins Independently Induce Numerical and Structural Chromosome Instability 1

  2002cited by this paper
• Human papillomavirus and cancer: the epidemiological evidence.

  2000cited by this paper
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

  1999cited by this paper
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

  1995cited by this paper
• Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

  1995cited by this paper
• Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes.

  1993cited by this paper
• Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes

  1993cited by this paper
• Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

  1992cited by this paper
• Viruses in human cancers

  1991cited by this paper
• Viruses in human cancers.

  1991cited by this paper

• HPV16 CpG Methylation Contributes to Cervical Carcinogenesis by Regulating HPV16 Tumorigenesis‐Related Genes

  2025cites this paper
• Effects of CpG sites methylation modification of HPV16 integration essential gene on the proliferation of cervical cancer cells

  2023cites this paper
• The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysis

  2019cites this paper
• Increased HPV L1 gene methylation and multiple infection status lead to the difference of cervical epithelial cell lesion in different ethnic women of Xinjiang, China

  2017cites this paper
• Detection of cervical intraepithelial neoplasia with HPVE6/E7 mRNA among women with atypical squamous cells of unknown significance

  2017cites this paper
• Moleküler Tanıda Yüksek Çözünürlüklü Erime Yöntemi ve Klinik Önemi

  2017cites this paper